Department of Dermatology, Epidemiology in dermatology and evaluation of therapeutics (EpiDermE EA 7379, University Hospital Henri Mondor), University Paris-Est Créteil (UPEC), FR-94010 Créteil, France. E-mail:
Acta Derm Venereol. 2021 Jun 28;101(6):adv00480. doi: 10.2340/00015555-3788.
The use of sunscreens is recommended to limit the impact of sun exposure on the skin. The objective of this study was to examine the relationship between sunscreen sales and melanoma in 4 different countries with diverse sunscreen regulations. Data from publicly avail-able databases were examined for Sweden, England, Australia, and the USA from 1999 to 2018. The association between incidence of melanoma and sunscreen sales was estimated using a generalized estimating equation, and modelling was used to predict melanoma cases. Incidence of melanoma was positively associated with sunscreen sales in England, Australia, and the USA, and negatively associated with sunscreen sales in Sweden. Growth rates in melanoma cases of 0.42%, 16.7%, 19.1% and 12.2% were predicted for Sweden, England, Australia, and the USA, respectively. The differences observed between England, Australia, and the USA, on the one hand, and Sweden, on the other hand, are consistent with the adoption of strong regulations requiring the use of ultraviolet A blocking agents in sunscreens.
建议使用防晒霜来限制阳光对皮肤的影响。本研究的目的是研究在防晒法规不同的 4 个国家中,防晒霜销售与黑色素瘤之间的关系。从 1999 年到 2018 年,从瑞典、英国、澳大利亚和美国的公开数据库中检查了数据。使用广义估计方程估计黑色素瘤发病率与防晒霜销售之间的关联,并使用模型预测黑色素瘤病例。在英国、澳大利亚和美国,黑色素瘤的发病率与防晒霜的销售呈正相关,而在瑞典则呈负相关。预测瑞典、英国、澳大利亚和美国的黑色素瘤病例增长率分别为 0.42%、16.7%、19.1%和 12.2%。英国、澳大利亚和美国与瑞典之间观察到的差异与采用要求在防晒霜中使用紫外线 A 阻断剂的严格法规一致。